JOURNAL OF VIROLOGY, Oct. 1998, p Vol. 72, No. 10. Copyright 1998, American Society for Microbiology. All Rights Reserved.
|
|
- Daniel Pitts
- 5 years ago
- Views:
Transcription
1 JOURNAL OF VIROLOGY, Oct. 1998, p Vol. 72, No X/98/$ Copyright 1998, American Society for Microbiology. All Rights Reserved. Cell Surface Proteoglycans Are Necessary for A27L Protein-Mediated Cell Fusion: Identification of the N-Terminal Region of A27L Protein as the Glycosaminoglycan-Binding Domain JYE-CHIAN HSIAO, 1,2 CHE-SHENG CHUNG, 1 AND WEN CHANG 1 * Institute of Molecular Biology, Academia Sinica, Nankang, 1 and Institute of Cell and Molecular Biology, Taipei Medical College, Taipei, 2 Taiwan, Republic of China Received 5 May 1998/Accepted 8 July 1998 We previously showed that vaccinia virus infection of BSC40 cells was blocked by soluble heparin, suggesting that cell surface heparan sulfate mediates vaccinia virus binding (C.-S. Chung, J.-C. Hsiao, Y.-S. Chang, and W. Chang, J. Virol. 72: , 1998). In this study, we extended our previous work and demonstrated that soluble A27L protein bound to heparan sulfate on cells and interfered with vaccinia virus infection at a postbinding step. In addition, we investigated the structure of A27L protein that provides for its binding to heparan sulfate on cells. A mutant of A27L protein, named D-A27L, devoid of a cluster of 12 amino acids rich in basic residues, was constructed. In contrast to the soluble A27L protein, purified D-A27L protein was inactive in all of our assays, including binding to heparin in vitro, binding to heparan sulfate on cells, and the ability to block virus infection. These data demonstrated that the N-terminal region acts as a glycosaminoglycan (GAG)-binding domain critical for A27L protein binding to cells. Previously A27L protein was thought to be involved in fusion of virus-infected cells induced by acid treatment. When we investigated whether cell surface GAGs also participate in A27L-dependent fusion, our results indicated that soluble A27L protein blocked cell fusion, whereas D-A27L protein did not. Taken together, the results therefore demonstrated that A27L-mediated cell fusion is triggered by its interaction with cell surface GAGs through the N-terminal domain. * Corresponding author. Mailing address: Institute of Molecular Biology, Academia Sinica, Nankang, Taipei, Taiwan 11529, Republic of China. Phone: Fax: mbwen@ccvax.sinica.edu.tw Virus entry is a complicated process and often involves multiple stages with various viral and cellular factors (23, 40). Especially for enveloped viruses, it is generally accepted that viruses first bind to cell surface receptors to trigger a conformational change of the virus-receptor complexes (4). Subsequently, a second set of cellular molecules, named coreceptors or fusion factors, come into contact with viruses to initiate membrane fusion between the virion envelope and plasma membrane (28). Identification of these cell surface molecules has been time-consuming and labor-intensive; however, isolation of genes encoding these molecules has proved critical for revealing the mechanistic complexity of virus entry processes. For human immunodeficiency virus entry, recent data indicated that not only does cellular CD4 need to interact with viral envelope protein, but also a second accessory molecule such as chemokine receptor-5 (CCR5) plays essential roles in virus-induced fusion. Interactions of gp120 with both CD4 and CCR5 are necessary to induce conformational changes to expose the fusion peptide located at the N terminus of gp41 for membrane fusion (1 3, 6, 7, 15). Previous studies regarding herpes simplex virus (HSV) have also indicated complicated entry mechanisms (4). HSV is much larger and contains many membrane proteins on virions. Multiple viral proteins such as gb, -C, -D, -H, and -L were shown to be involved in virus entry (10, 18 20, 29). Some of these proteins, such as gb and gc, are now known to bind to glycosaminoglycans (GAGs) on cells, and the presence of gd allows further interactions of bound virions to bind to a coreceptor, HVEM, for fusion (8, 25, 38, 39). Although how fusion is triggered is still not yet known, identification of these cellular molecules provides a critical basis for future studies of HSV fusion mechanisms. Since vaccinia virus has a wide host range, it is conceivable that certain cellular components that are ubiquitously expressed on cells mediate virus entry. Our previous data suggested that recombinant A27L protein bound to heparan sulfate on BSC40 cells. In addition, BSC40 cells treated with sodium chlorate to block sulfation of GAG side chains became more resistant to vaccinia virus infection (12). We interpreted these results as indicating A27L protein interaction with the negative charges of sulfates on GAGs. We therefore looked for amino acid sequences on A27L protein that are basic or positively charged and suitable for interaction with sulfates (31). A stretch of 12 amino acids (aa) from aa 21 to 32 (STKAAKK PEAKR) rich in lysine and arginine is, in principle, ideal for charge interactions. This region was also present in the soluble A27L protein, which contained aa 21 to 84 and was shown to bind to cells (Fig. 1A) (12). The A27L hydropathy plot translated from the open reading frame predicts a membrane protein of 110 aa with a signal peptide from aa 1 to 20. Previously, the A27L protein on virions was purified, and the sequencing data indicated that the mature form starts at serine of aa 21, suggesting processing of the signal peptide (37). This placed the arginine- and lysine-rich region described above at the most external region of the N terminus for easy accessibility. Furthermore, several monoclonal antibodies (MAbs) that recognized overlapping epitopes within this region were able to neutralize vaccinia virus infection (27). It is likely that this
2 VOL. 72, 1998 NOTES 8375 FIG. 1. (A) Hydropathy plot of A27L protein containing 110 aa translated from the open reading frame. The ectodomains expressed in A27L and D-A27L proteins were shown as boxed regions, and the lysine- and arginine-rich region (aa 21 to 32) was drawn as a striped box. Individual amino acid sequences from positions 21 to 32 were shown on the top of the striped area. The numbers of amino acids shown for the A27L and D-A27L proteins are identical to the numbering of amino acid sequences in the hydropathy plot. The boxed regions are aligned with the hydropathy plot to demonstrate that the A27L protein contains a hydrophilic ectodomain immediately adjacent to the signal peptide of aa 1 to 20. (B) Purification of D-A27L protein. Construction of D-A27L protein was similar to that of A27L protein, as described previously (13). In brief, PCR primers corresponding to different A27L DNA sequences were used to amplify the DNA fragment containing the ectodomains of D-A27L protein. The DNA was cloned into pet21a( ) and transformed into BL21(DE3), and the resulting recombinant D-A27L protein contains a T7 tag at the N terminus and a hexahistidine tag at the C terminus to allow purification with a nickel column. Both soluble A27L protein (lane 1) and D-A27L protein (lane 2) were purified as described above, separated by sodium dodecyl sulfate-polyacrylamide (12%) gel electrophoresis (SDS-PAGE), and stained with Coomassie brilliant blue. (C) D-A27L protein does not bind to the heparin column in vitro. Purified A27L (lanes 1 to 5) and D-A27L (lanes 6 to 10) proteins were incubated with heparin- Sepharose beads (lanes 4, 5, 9, and 10) or control Sepharose beads (lanes 2, 3, 7, and 8) at 4 C for 60 min, and the supernatant was collected after a brief centrifugation. The beads were washed three times, and the volumes of the bound (lanes 2, 4, 7, and 9) or supernatant (lanes 3, 5, 8, and 10) samples were adjusted so that an equal proportion of each sample was loaded on a 12% polyacrylamide SDS-PAGE gel. Purified A27L and D-A27L proteins were shown as controls in lanes 1 and 6, respectively. The gel was transferred for Western blot analysis with a MAb specific for A27L protein (1:500). The two bands in each lane represent the dimeric (top) and the monomeric (bottom) forms of the proteins. Kd, kilodaltons. N-terminal region modulates the functions of A27L protein in virus entry. A mutant construct, D-A27L, was generated to express soluble proteins in bacteria. D-A27L encodes the open reading frame sequences from aa 33 to 84. Compared with our original A27L ectodomain construct, D-A27L protein lacks aa 21 to 32 from the N terminus (Fig. 1A). Both A27L and D-A27L proteins contain a hexahistidine tag and were purified with nickel columns (Fig. 1B). To test if this deletion removed the ability of A27L protein to bind to GAGs, both A27L and D-A27L proteins were incubated with heparin CL6B beads, respectively, in vitro, and after washing, the bound fractions and the flowthrough were collected and analyzed by Western blotting with a serum specific for A27L protein (Fig. 1C). In the control, soluble A27L protein bound to heparin beads (lane 4), and very little of the protein was detected in the flowthrough (lane 5). This binding was specific to heparin, since A27L protein did not bind to beads alone (lane 2). In contrast, D-A27L protein did not bind to either control beads (lane 7) or heparin beads (lane 9). All of the D-A27L protein was detected in both of the flowthrough fractions (lanes 8 and 10). The results therefore demonstrated that the region of aa 21 to 32 is necessary for A27L protein binding to heparin beads in vitro. We extended the in vitro analysis described above to determine if soluble A27L protein binding to heparan sulfate on cells is also mediated by the same N-terminal domain. We monitored the ability of D-A27L protein to compete with soluble A27L protein for cell binding by using fluorescence-activated cell sorter analysis. Biotinylated A27L protein bound specifically to HeLa cells and revealed a significant shift in fluorescence staining on cell surfaces (Fig. 2A). The amount of A27L protein bound to cells was significantly reduced when soluble heparin was added as a competitor, but not with chondroitin sulfate or dermantan sulfate (data not shown). When cells were incubated with 10-fold excessive amounts of unlabeled A27L protein to compete with biotinylated A27L protein for cell binding, the fluorescence staining detected was significantly reduced (Fig. 2B). When D-A27L protein was used as a cold competitor, no decrease in fluorescence was observed, indicating that D-A27L protein did not compete with A27L protein for cell binding (Fig. 2C). Failure of D-A27L protein to bind to heparin beads correlates with the protein s inability to bind to cells, confirming that the N-terminal domain is necessary for A27L interaction with heparan sulfate on cells. This was not only restricted to HeLa cells, since other cell lines, such as BSC40 and mouse L cells, were also tested and similar results were obtained (data not shown). A27L protein is an envelope protein on the surface of intracellular mature viruses, and antibodies against A27L protein neutralized vaccinia virus infection (30 32, 35). If A27L protein indeed mediates vaccinia virus binding to heparan sulfate on cells, it is likely that soluble A27L protein would interfere with vaccinia virus infection. With purified D-A27L protein, the involvement of the GAG-binding domain in virus infection could be assessed. BSC40 cells were infected with vaccinia virus in the presence of soluble A27L or D-A27L protein, and plaque numbers were determined 3 days later. As shown in Fig. 3A, soluble A27L protein blocked plaque formation in a dosage-dependent manner, with 23% inhibition at the 1- g protein level. Inhibition was saturated at 61 and 66% for 10 and 100 g, respectively. D-A27L protein did not have any significant effect on virus infection, indicating the GAGbinding domain is essential for this inhibitory effect. We then checked if soluble A27L protein blocked virus infection at an early stage. Cells were infected with a recombinant vaccinia virus, vmj360, in the presence of soluble A27L or D-A27L protein (14). Cell lysates were prepared at 2 h postinfection and assayed for lacz expression from an early viral promoter (Fig. 3B). Incubation of cells with 1 g of soluble A27L protein blocked approximately 51% of viral infection. With 10 g of A27L protein, blockage of viral infection increased to 60% inhibition. The results appeared consistent with the observations in Fig. 3A. D-A27L protein did not inhibit viral gene expression from the 0.1- to 10- g range tested. Presumably, D-A27L protein did not bind to cells and
3 8376 NOTES J. VIROL. FIG. 2. D-A27L protein did not compete with biotinylated A27L protein for cell binding. (A) HeLa cells were incubated with phosphate-buffered saline alone (gray line in panel A), biotinylated A27L protein alone (shaded areas in panels A, B, and C), or biotinylated A27L protein in the presence of 10-fold excess of cold A27L protein (gray line in panel B) or D-A27L protein (gray line in panel C) at 4 C for 30 min. Cells were washed three times, and phycoerythrin-conjugated streptavidin (1:100) was added for another 30-min incubation. After washing, cells were analyzed by a fluorescence-activated cell sorter (excitation, 488 nm; emission, 578 nm). was ineffective in blocking virus infection. A27L protein required the N-terminal sequences in order to inhibit virus infection, suggesting that A27L protein interferes with the virus entry process. The ability of A27L protein to block vaccinia virus infection suggested two possible mechanisms: it could block vaccinia FIG. 3. Soluble A27L protein but not D-A27L protein blocked vaccinia virus entry at the postbinding step. (A) Plaque reduction by soluble A27L protein. BSC40 cells were incubated first with various amounts of soluble A27L or D-A27L protein (1, 10, or 100 g in200 l) at 4 C for 30 min and subsequently infected with vaccinia virus (600 PFU) for another 4 C for 30 min. Cells were washed with citrate buffer (40 mm citric acid, 10 mm KCl, 135 mm NaCl [ph 3.0]) for 1 min, washed with phosphate-buffered saline, and overlaid with agar. Plaque numbers were determined 3 days later. (B) Viral early gene expression was reduced by A27L protein. Cells were incubated with soluble A27L or D-A27L protein (0.1, 1, or 10 g in100 l) at 4 C for 30 min and subsequently infected with vmj360 at a multiplicity of infection of 5 PFU per cell for another 4 C for 30 min. Cells were washed twice with phosphate-buffered saline and harvested at 2 h postinfection. Lysates were prepared for -galactosidase ( -gal) assays as described before (3). O.D., optical density. (C) Vaccinia virus binding to cells was not affected by A27L protein. BSC40 cells were preincubated with soluble proteins (1, 10, or 100 g) at 4 C for 30 min and subsequently infected with vaccinia virus at a multiplicity of infection of 10 PFU per cell at 4 C for 30 min. Cells were washed, lysed in sodium dodecyl sulfate-containing buffer, and loaded onto 10% polyacrylamide sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel for Western blot analysis with an antiserum against vaccinia virions (V). M, lysate from mock-infected cells. virus adsorption, or it could block virus fusion or penetration. For envelope viruses, binding and fusion are two distinct steps, and soluble viral proteins that interfere with either process have been previously described (17, 26, 38, 39). We performed virus binding assays to quantitate the amount of vaccinia virions bound to cells in the presence of soluble A27L protein. BSC40 cells were incubated with soluble protein and infected with vaccinia virus. Cells were then immediately harvested, and lysates were prepared for Western blot analysis with an antiserum against vaccinia virions (Fig. 3C). The amount of viruses bound to cells appeared unchanged, regardless of the concentration of soluble A27L protein used. This indicated that addition of soluble A27L protein did not reduce vaccinia virus binding to cells and instead blocked virus infection at the fusion or penetration stage. This result may not be too surprising, since A27L protein was shown to induce cell fusion of vaccinia virus-infected cells by acid treatment (31, 32). In addition, MAb C3 against A27L protein blocked cell fusion with-
4 VOL. 72, 1998 NOTES 8377 Downloaded from FIG. 4. Soluble A27L protein blocked fusion of cells infected by WR32-7/Ind14K. BSC40 cells were either mock infected (A) or were infected with a recombinant virus, WR32-7/Ind14K, at a multiplicity of infection of 5 PFU per cell in the presence (C to E) or in the absence (B) of IPTG. After infection, cells were incubated with medium alone (A to C) or medium containing A27L protein (D) or D-A27L protein (E) for another 24 h and photographed. out affecting virus binding (32, 35). However, it was not known how A27L protein triggers fusion, and no cell surface components involved in fusion have been identified. Since the N-terminal region of A27L protein acts as a GAGbinding domain, it provides a clue for understanding the mechanism of A27L-dependent cell fusion. We obtained a recombinant virus, WR32-7/Ind14K, in which expression of A27L protein was regulated by addition of isopropyl- -D-thiogalactopyranoside (IPTG) to the culture medium (33, 34). Cell fusion was strictly dependent on A27L protein expression and was readily observed around 18 h postinfection in the presence of IPTG (34). This virus allowed us to determine fusion formation without acid treatment and provided a more convenient assay. BSC40 cells infected by WR32-7/Ind14K developed cell fusion at neutral ph when IPTG was added to the culture medium (Fig. 4C), whereas no fusion was observed when IPTG was omitted (Fig. 4B). When these infected cells were incubated with soluble A27L protein, cell fusion was significantly blocked (Fig. 4D). Incubation of D-A27L protein with infected cells had no inhibitory effect, and cell fusion developed to a similar extent to the control infected cells (Fig. 4E). Taken together, removal of the GAG-binding domain of D-A27L protein eliminated its biological activities in both cell binding and cell fusion. This suggests that cell binding through GAG interaction is essential for A27L protein to mediate cell fusion. This finding may provide an explanation for several previous observations. For example, several MAbs that recognize epitopes within this region may neutralize virus infection due to interrupting virus and GAG interactions (13, 27). Mutations or deletions within the N-terminal sequences that were known to inactivate A27L functions may also be due to an inability to interact with GAGs (21, 22). What is the role of A27L protein in vaccinia virus binding and fusion? It is apparent that A27L protein and GAG interaction could act as the initial stage of virus infection, since the charge interactions through GAGs were often described as nonspecific and with low affinity (4). It seems likely that other high-affinity interactions between cells and bound viruses will be required to provide specificity. Incubation of cells with soluble heparin blocked virus binding to cells, whereas soluble A27L protein did not (Fig. 3C) (12). This would suggest that on December 4, 2018 by guest
5 8378 NOTES J. VIROL. perhaps there are multiple viral proteins mediating virus binding to GAGs. Blocking of virus adsorption could only be achieved when all of these interactions were simultaneously blocked by heparin. This would explain the failure of soluble A27L protein to inhibit virus binding. This may also explain that A27L protein is not essential for virus infection, since binding to GAGs may be shared by other viral membrane proteins, similar to gb and gc in HSV-1 (10, 24, 25). There have been reports suggesting that A27L protein was required in virus and cell fusion. A MAb against A27L, C3, was reported to block vaccinia virus infection without affecting virus binding (32). Dequenching analysis to demonstrate that intracellular mature virus enters cells by membrane fusion revealed that virus and cell membrane fusion was blocked by MAb C3 (16). Since we do not know the epitope that MAb C3 recognizes, it is unclear how MAb C3 blocks virus fusion. Inhibition of virus infection by soluble A27L protein without affecting virus attachment was also consistent with a role in fusion. We speculate that soluble A27L protein bound to GAGs on cells, created a steric hindrance, and interfered with conformational changes of virus-gag complexes, which otherwise could have been converted into fusiongenic intermediates. In this model, we do not think the A27L protein itself serves as a fusion protein. Viral fusion proteins such as hemagglutinin (HA2) and gp41 contain hydrophobic amino acids at the N terminus which often were described as fusion peptides (9, 11). There is no similar structure on A27L protein which may serve as the fusion peptide. In addition, vaccinia virus cell fusion could be mediated by multiple viral proteins. Other proteins, such as F13L, B5R, and A34R, were also shown to be required for cell fusion of virus-infected cells (5, 41, 42). With few conserved structures among these viral proteins, it appeared less likely that they all contain fusion peptides to participate in the fusion process. Rather, it may indicate that these viral proteins, including A27L protein, somehow regulate the activity of the fusion machinery. Besides, there are several viral proteins known to interact with A27L protein, such as A13L, A14L, and A17L proteins, and their roles in fusion need to be determined in the future (30, 36). In conclusion, our study revealed the importance of the N-terminal domain of A27L protein in the vaccinia virus adsorption to GAGs on cells. This interaction also controls the ability of A27L protein to trigger cell fusion. Our mapping of the GAG-binding domain allowed us to begin dissecting the mechanistic complexity involved in virus entry. The study of individual membrane proteins should enable us to identify other viral and cellular proteins which participate in the vaccinia virus entry process. We thank G. Smith and J. F. Rodriguez for providing the recombinant WR32-7/Ind14K virus. We also thank Douglas Platt for carefully reviewing the manuscript. This work was supported by grants from Academia Sinica and the National Science Council (NSC B ) of the Republic of China. REFERENCES 1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: Baiocchi, M., E. Olivetta, C. Chelucci, A. C. Santarcangelo, R. Bona, P. d Aloja, U. Testa, N. Komatsu, P. Verani, and M. Federico Human immunodeficiency virus (HIV)-resistant CD4 UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection. Blood 89: Balter, M A second coreceptor for HIV in early stages of infection. Science 272: Bentz, J Viral fusion mechanisms. CRC Press, Boca Raton, Fla. 5. Blasco, R., and B. Moss Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65: Bradbury, J HIV-1-resistant individuals may lack HIV-1 coreceptor. Lancet 348: Broder, C. C., and D. S. Dimitrov HIV and the 7-transmembrane domain receptors. Pathobiology 64: Bryne, K. M., D. W. Horohov, and K. G. Kousoulas Glycoprotein B of bovine herpesvirus-1 binds heparin. Virology 209: Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley Structure of influenza haemagglutinin at the ph of membrane fusion. Nature 371: Cai, W., B. Gu, and S. Person Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62: (Erratum, 62:4438.) 11. Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim Core structure of gp41 from the HIV envelope glycoprotein. Cell 89: Chung, C.-S., J.-C. Hsiao, Y.-S. Chang, and W. Chang A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72: Czerny, C. P., S. Johann, L. Holzle, and H. Meyer Epitope detection in the envelope of intracellular naked orthopox viruses and identification of encoding genes. Virology 200: Davison, A. J., and B. Moss Structure of vaccinia virus early promoters. J. Mol. Biol. 210: Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. D. Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: Doms, R. W., R. Blumenthal, and B. Moss Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64: Fuller, A. O., and W.-C. Lee Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gd and gh in penetration. J. Virol. 66: Fuller, A. O., R. E. Santos, and P. G. Spear Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J. Virol. 63: Fuller, A. O., and P. G. Spear Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proc. Natl. Acad. Sci. USA 84: Gerber, S. I., B. J. Belval, and B. C. Herold Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214: Gong, S., C. Lai, S. Dallo, and M. Esteban A single point mutation of Ala-25 to Asp in the 14,000-M r envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus. J. Virol. 63: Gong, S. C., C. F. Lai, and M. Esteban Vaccinia virus induces cell fusion at acid ph and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178: Haywood, A. M Virus receptors: binding, adhesion strengthening, and changes in viral structure. J. Virol. 68: Herold, B. C., R. J. Visalli, N. Susmarski, C. R. Brandt, and P. G. Spear Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulfate and glycoprotein B. J. Gen. Virol. 75: Herold, B. C., D. WuDunn, N. Soltys, and P. G. Spear Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65: Johnson, D. C., R. L. Burke, and T. Gregory Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. J. Virol. 64: Meyer, H., N. Osterrieder, and C.-P. Czerny Identification of binding sites for neutralizing monoclonal antibodies on the 14-kDa fusion protein of orthopox viruses. Virology 200: Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family. Cell 87: Muggeridge, M. I., W. C. Wilcox, G. H. Cohen, and R. J. Eisenberg Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity. J. Virol. 64: Rodriguez, D., J.-R. Rodriguez, and M. Esteban The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J. Virol. 67: Rodriguez, J. F., and M. Esteban Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J. Virol. 61: Rodriguez, J. F., R. A. Janeczko, and M. Esteban Isolation and
6 VOL. 72, 1998 NOTES 8379 characterization of neutralizing monoclonal antibodies to vaccinia virus. J. Virol. 56: Rodriguez, J. F., and G. L. Smith Inducible gene expression from vaccinia virus vectors. Virology 177: Rodriguez, J. F., and G. L. Smith IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and ingress. Nucleic Acids Res. 18: Rodriguez, J. F., E. Paez, and M. Esteban A 14,000-M r enveloped protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J. Virol. 61: Rodriguez, J. R., C. Risco, J. L. Carrascosa, M. Esteban, and D. Rodriguez Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15 kilodalton envelope protein. J. Virol. 71: Takahashi, T., M. Oie, and Y. Ichihashi N-terminal amino acid sequences of vaccinia virus structural proteins. Virology 202: Tal-Singer, R., C. Peng, M. P. de Leon, W. R. Abrams, B. W. Banfield, F. Tufaro, G. H. Cohen, and R. J. Eisenberg Interaction of herpes simplex virus glycoprotein gc with mammalian cell surface molecules. J. Virol. 69: Whitbeck, J. C., C. Peng, H. Lou, R. Xu, S. H. Willis, M. Ponce De Leon, T. Peng, A. V. Nicola, R. I. Montgomery, M. S. Warner, A. M. Soulika, L. A. Spruce, W. T. Moore, J. D. Lambris, P. G. Spear, G. H. Cohen, and R. J. Eisenberg Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71: Wimmer, E Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 41. Wolffe, E. J., S. N. Isaacs, and B. Moss Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67: (Erratum, 67: ) 42. Wolffe, E. J., E. Katz, A. Weisberg, and B. Moss The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J. Virol. 71:
Herpesvirus Entry Mediator HVEM Mediates Cell-Cell Spread in BHK(TK ) Cell Clones
JOURNAL OF VIROLOGY, Feb. 1998, p. 1411 1417 Vol. 72, No. 2 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Herpesvirus Entry Mediator HVEM Mediates Cell-Cell Spread in BHK(TK )
More informationIdentification of Functional Domains in the 14-Kilodalton Envelope Protein (A27L) of Vaccinia Virus
JOURNAL OF VIROLOGY, Nov. 1999, p. 9098 9109 Vol. 73, No. 11 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Identification of Functional Domains in the 14-Kilodalton
More informationStructural vs. nonstructural proteins
Why would you want to study proteins associated with viruses or virus infection? Receptors Mechanism of uncoating How is gene expression carried out, exclusively by viral enzymes? Gene expression phases?
More informationIdentification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist
Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1
More informationVaccinia Virus Penetration Requires Cholesterol and Results in Specific Viral Envelope Proteins Associated with Lipid Rafts
JOURNAL OF VIROLOGY, Feb. 2005, p. 1623 1634 Vol. 79, No. 3 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.3.1623 1634.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Vaccinia Virus
More informationRecombinant Protein Expression Retroviral system
Recombinant Protein Expression Retroviral system Viruses Contains genome DNA or RNA Genome encased in a protein coat or capsid. Some viruses have membrane covering protein coat enveloped virus Ø Essential
More informationUnder the Radar Screen: How Bugs Trick Our Immune Defenses
Under the Radar Screen: How Bugs Trick Our Immune Defenses Session 7: Cytokines Marie-Eve Paquet and Gijsbert Grotenbreg Whitehead Institute for Biomedical Research HHV-8 Discovered in the 1980 s at the
More informationMaterials and Methods , The two-hybrid principle.
The enzymatic activity of an unknown protein which cleaves the phosphodiester bond between the tyrosine residue of a viral protein and the 5 terminus of the picornavirus RNA Introduction Every day there
More informationA role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1
Journal of General Virology (2004), 85, 805 809 DOI 10.1099/vir.0.19641-0 Short Communication Correspondence Deepak Shukla dshukla@uic.edu A role for 3-O-sulfated heparan sulfate in cell fusion induced
More informationTel: ; Fax: ;
Tel.: +98 216 696 9291; Fax: +98 216 696 9291; E-mail: mrasadeghi@pasteur.ac.ir Tel: +98 916 113 7679; Fax: +98 613 333 6380; E-mail: abakhshi_e@ajums.ac.ir A Soluble Chromatin-bound MOI 0 1 5 0 1 5 HDAC2
More informationSupplementary Material
Supplementary Material Nuclear import of purified HIV-1 Integrase. Integrase remains associated to the RTC throughout the infection process until provirus integration occurs and is therefore one likely
More informationJOURNAL OF VIROLOGY, Aug. 1999, p Vol. 73, No. 8. Copyright 1999, American Society for Microbiology. All Rights Reserved.
JOURNAL OF VIROLOGY, Aug. 1999, p. 6370 6379 Vol. 73, No. 8 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. The CC-Chemokine RANTES Increases the Attachment
More informationHveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system
Journal of NeuroVirology, 7: 476± 480, 2001 c 2001 Taylor & Francis ISSN 1355± 0284/01 $12.00+.00 Short Communication HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons,
More informationAnti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZO Food Research, The Netherlands
Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZ Food Research, The Netherlands René Floris has studied chemistry at Leiden University and obtained his PhD degree
More informationARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za
ARV Mode of Action Mode of Action Mode of Action - NRTI Mode of Action - NNRTI Mode of Action - Protease Inhibitors Mode of Action - Integrase inhibitor Mode of Action - Entry Inhibitors Mode of Action
More informationCell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system
Cell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system Basic Elements of cell signaling: Signal or signaling molecule (ligand, first messenger) o Small molecules (epinephrine,
More informationGlycosaminoglycans: Anionic polysaccharide chains made of repeating disaccharide units
Glycosaminoglycans: Anionic polysaccharide chains made of repeating disaccharide units Glycosaminoglycans present on the animal cell surface and in the extracellular matrix. Glycoseaminoglycans (mucopolysaccharides)
More informationDr. Ahmed K. Ali Attachment and entry of viruses into cells
Lec. 6 Dr. Ahmed K. Ali Attachment and entry of viruses into cells The aim of a virus is to replicate itself, and in order to achieve this aim it needs to enter a host cell, make copies of itself and
More informationHIV INFECTION: An Overview
HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ
More informationThe Immunoassay Guide to Successful Mass Spectrometry. Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013
The Immunoassay Guide to Successful Mass Spectrometry Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013 What is it? Hey! Look at that! Something is reacting in here! I just wish I knew what it
More informationCONTRACTING ORGANIZATION: Rush University Medical Center Chicago, IL 60612
AD Award Number: W81XWH-11-1-0302 TITLE: Yin and Yang of Heparanase in breast Tumor Initiation PRINCIPAL INVESTIGATOR: Xiulong Xu, Ph.D. CONTRACTING ORGANIZATION: Rush University Medical Center Chicago,
More informationSupplementary Information
Supplementary Information Supplementary Figure 1. CD4 + T cell activation and lack of apoptosis after crosslinking with anti-cd3 + anti-cd28 + anti-cd160. (a) Flow cytometry of anti-cd160 (5D.10A11) binding
More informationFusion of Intra- and Extracellular Forms of Vaccinia Virus with the Cell Membrane
JOURNAL OF VIROLOGY, OCt. 199, p. 4884-4892 22-538X/9/14884-9$2./ Copyright 199, American Society for Microbiology Vol. 64, No. 1 Fusion of Intra- and Extracellular Forms of Vaccinia Virus with the Cell
More informationSoluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells
Journal of General Virology (2007), 88, 1075 1079 DOI 10.1099/vir.0.82476-0 Short Communication Correspondence Deepak Shukla dshukla@uic.edu Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex
More informationModified FGF4 Signal Peptide Inhibits Entry of Herpes Simplex Virus Type 1
JOURNAL OF VIROLOGY, Mar. 2001, p. 2634 2645 Vol. 75, No. 6 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.6.2634 2645.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Modified FGF4
More informationAdvances in gene encoding proteins of human herpesvirus 6
2009 9 4 3 Journal of Microbes and Infection, September 2009, Vol. 4, No. 3 165 6 1, 2 1., 241000; 2., 210029 : 6 ( HHV-6) DNA, HHV-6 80 100, ( IE) DNA DNA HHV-6 : 6 ; ; Advances in gene encoding proteins
More informationReceived 30 January 2002/Accepted 18 December 2002
JOURNAL OF VIROLOGY, Mar. 2003, p. 3634 3646 Vol. 77, No. 6 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.6.3634 3646.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Rational Site-Directed
More informationSize nm m m
1 Viral size and organization Size 20-250nm 0.000000002m-0.000000025m Virion structure Capsid Core Acellular obligate intracellular parasites Lack organelles, metabolic activities, and reproduction Replicated
More informationRole of Cell-Associated Enveloped Vaccinia Virus in Cell-to-Cell Spread
JOURNAL OF VIROLOGY, July 1992, p. 4170-4179 Vol. 66, No. 7 0022-538X/92/074170-10$02.00/0 Copyright 1992, American Society for Microbiology Role of Cell-Associated Enveloped Vaccinia Virus in Cell-to-Cell
More informationProblem-solving Test: The Mechanism of Protein Synthesis
Q 2009 by The International Union of Biochemistry and Molecular Biology BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION Vol. 37, No. 1, pp. 58 62, 2009 Problem-based Learning Problem-solving Test: The Mechanism
More information7.06 Cell Biology EXAM #3 April 24, 2003
7.06 Spring 2003 Exam 3 Name 1 of 8 7.06 Cell Biology EXAM #3 April 24, 2003 This is an open book exam, and you are allowed access to books and notes. Please write your answers to the questions in the
More informationCell Membranes. Dr. Diala Abu-Hassan School of Medicine Cell and Molecular Biology
Cell Membranes Dr. Diala Abu-Hassan School of Medicine Dr.abuhassand@gmail.com Cell and Molecular Biology Organelles 2Dr. Diala Abu-Hassan Membrane proteins Major components of cells Nucleic acids DNA
More informationWeek 5 Section. Junaid Malek, M.D.
Week 5 Section Junaid Malek, M.D. HIV: Anatomy Membrane (partiallystolen from host cell) 2 Glycoproteins (proteins modified by added sugar) 2 copies of RNA Capsid HIV Genome Encodes: Structural Proteins
More informationLuminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells
Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2016 Contents Supporting Information Luminescent platforms for monitoring changes in the
More informationSupplementary materials
Supplementary materials Chemical library from ChemBridge 50,240 structurally diverse small molecule compounds dissolved in DMSO Hits Controls: No virus added μ Primary screening at 20 g/ml of compounds
More informationRama Abbady. Odai Bani-Monia. Diala Abu-Hassan
5 Rama Abbady Odai Bani-Monia Diala Abu-Hassan Lipid Rafts Lipid rafts are aggregates (accumulations) of sphingolipids. They re semisolid clusters (10-200 nm) of cholesterol and sphingolipids (sphingomyelin
More informationReceptor-triggered membrane association of a model retroviral glycoprotein
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 2580 2585, March 1998 Microbiology Receptor-triggered membrane association of a model retroviral glycoprotein RACHEL L. DAMICO, JOANNE CRANE, AND PAUL BATES* Department
More informationQuantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles
Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles Amin Feizpour Reinhard Lab Department of Chemistry and the Photonics Center, Boston University, Boston, MA May 2014
More informationHIV & AIDS: Overview
HIV & AIDS: Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR VJ TEMPLE 1 What
More informationMembrane Is Regulated by a Viral Envelope Glycoprotein: Effect of a Point Mutation
JOURNAL OF VIROLOGY, June 1993, p. 3319-3325 0022-538XJ93/063319-07$02.00/0 Copyright 1993, American Society for Microbiology Vol. 67, No. 6 Dissociation of Progeny Vaccinia Virus from the Cell Membrane
More informationReceived 15 October 1997/Accepted 17 February 1998
JOURNAL OF VIROLOGY, June 1998, p. 4765 4774 Vol. 72, No. 6 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Mutations in the Leucine Zipper-Like Heptad Repeat Sequence of Human
More informationNature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1
Supplementary Figure 1 Design of isolated protein and RNC constructs, and homogeneity of purified RNCs. (a) Schematic depicting the design and nomenclature used for all the isolated proteins and RNCs used
More informationDiscovery. Gerry Graham* and Rob Nibbs SUMMARY BACKGROUND
D6 Gerry Graham* and Rob Nibbs Cancer Research Campaign Laboratories, The Beaton Institute for Cancer Research, Garscube Estate Switchback Road, Bearsdon, Glasgow G61 1BD, UK * corresponding author tel:
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar
More informationSupplemental information contains 7 movies and 4 supplemental Figures
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplemental information contains 7 movies and 4 supplemental Figures Movies: Movie 1. Single virus tracking of A4-mCherry-WR MV
More informationSUPPLEMENTARY INFORMATION
Supplementary Figures Supplementary Figure S1. Binding of full-length OGT and deletion mutants to PIP strips (Echelon Biosciences). Supplementary Figure S2. Binding of the OGT (919-1036) fragments with
More informationInnate Immunity & Inflammation
Innate Immunity & Inflammation The innate immune system is an evolutionally conserved mechanism that provides an early and effective response against invading microbial pathogens. It relies on a limited
More informationAND JEREMY LUBAN 1,2 *
JOURNAL OF VIROLOGY, Oct. 1999, p. 8527 8540 Vol. 73, No. 10 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Human Immunodeficiency Virus Type 1 Gag Polyprotein
More informationHuman Cathepsin D ELISA Kit
GenWay Biotech, Inc. 6777 Nancy Ridge Drive San Diego, CA 92121 Phone: 858.458.0866 Fax: 858.458.0833 Email: techline@genwaybio.com http://www.genwaybio.com Human Cathepsin D ELISA Kit Catalog No. GWB-J4JVV9
More informationFigure S1. (A) SDS-PAGE separation of GST-fusion proteins purified from E.coli BL21 strain is shown. An equal amount of GST-tag control, LRRK2 LRR
Figure S1. (A) SDS-PAGE separation of GST-fusion proteins purified from E.coli BL21 strain is shown. An equal amount of GST-tag control, LRRK2 LRR and LRRK2 WD40 GST fusion proteins (5 µg) were loaded
More informationVirus Entry/Uncoating
Virus Entry/Uncoating Delivery of genome to inside of a cell Genome must be available for first step of replication The Problem--barriers to infection Virion Barriers: Non-enveloped viruses capsid Enveloped
More informationVaccinia virus belongs to the genus Orthopoxvirus of the family
Vaccinia Mature Virus Fusion Regulator A26 Protein Binds to A16 and G9 Proteins of the Viral Entry Fusion Complex and Dissociates from Mature Virions at Low ph Shu-Jung Chang, a,b Ao-Chun Shih, a,b Yin-Liang
More informationBioluminescence Resonance Energy Transfer (BRET)-based studies of receptor dynamics in living cells with Berthold s Mithras
Bioluminescence Resonance Energy Transfer (BRET)-based studies of receptor dynamics in living cells with Berthold s Mithras Tarik Issad, Ralf Jockers and Stefano Marullo 1 Because they play a pivotal role
More informationT H E J O U R N A L O F C E L L B I O L O G Y
T H E J O U R N A L O F C E L L B I O L O G Y Supplemental material Krenn et al., http://www.jcb.org/cgi/content/full/jcb.201110013/dc1 Figure S1. Levels of expressed proteins and demonstration that C-terminal
More informationHerpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Herpesviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped icosahedral capsid (T=16), diameter 125 nm Diameter of enveloped virion 200 nm Capsid
More informationnumber Done by Corrected by Doctor Ashraf Khasawneh
number 3 Done by Mahdi Sharawi Corrected by Doctor Ashraf Khasawneh *Note: Please go back to the slides to view the information that the doctor didn t mention. Prions Definition: Prions are rather ill-defined
More informationPolyomaviridae. Spring
Polyomaviridae Spring 2002 331 Antibody Prevalence for BK & JC Viruses Spring 2002 332 Polyoma Viruses General characteristics Papovaviridae: PA - papilloma; PO - polyoma; VA - vacuolating agent a. 45nm
More informationInteraction of NPR1 with basic leucine zipper protein transcription factors that bind sequences required for salicylic acid induction of the PR-1 gene
Interaction of NPR1 with basic leucine zipper protein transcription factors that bind sequences required for salicylic acid induction of the PR-1 gene YUELIN ZHANG, WEIHUA FAN, MARK KINKEMA, XIN LI, AND
More informationApplication of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma
Excerpt from MACS&more Vol 8 1/2004 Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma L. Davis Lupo and Salvatore T. Butera HIV and Retrovirology Branch,
More informationHuman Immunodeficiency Virus type 1 (HIV-1) gp120 / Glycoprotein 120 ELISA Pair Set
Human Immunodeficiency Virus type 1 (HIV-1) gp120 / Glycoprotein 120 ELISA Pair Set Catalog Number : SEK11233 To achieve the best assay results, this manual must be read carefully before using this product
More informationZool 3200: Cell Biology Exam 4 Part II 2/3/15
Name:Key Trask Zool 3200: Cell Biology Exam 4 Part II 2/3/15 Answer each of the following questions in the space provided, explaining your answers when asked to do so; circle the correct answer or answers
More informationViral Genetics. BIT 220 Chapter 16
Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationMBB 694:407, 115:511. Please use BLOCK CAPITAL letters like this --- A, B, C, D, E. Not lowercase!
MBB 694:407, 115:511 First Test Severinov/Deis Tue. Sep. 30, 2003 Name Index number (not SSN) Row Letter Seat Number This exam consists of two parts. Part I is multiple choice. Each of these 25 questions
More informationhexahistidine tagged GRP78 devoid of the KDEL motif (GRP78-His) on SDS-PAGE. This
SUPPLEMENTAL FIGURE LEGEND Fig. S1. Generation and characterization of. (A) Coomassie staining of soluble hexahistidine tagged GRP78 devoid of the KDEL motif (GRP78-His) on SDS-PAGE. This protein was expressed
More informationHUMAN IMMUNODEFICIENCY VIRUS
Futuro promisorio de la terapia antirretroviral: Nuevos blancos terapéuticos. María José Míguez, M.D., PhD., Universidad de Miami, EE.UU. HUMAN IMMUNODEFICIENCY VIRUS REVERSE TRANSCRIPTASA REPLICATION
More informationCD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120
CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120 Colin Wikholm and Isai Lopez BIOL 368: Bioinformatics Laboratory Department of Biology Loyola Marymount University November 15,
More informationSupplementary Information
Supplementary Information Supplementary Figure 1. EBV-gB 23-431 mainly exists as trimer in HEK 293FT cells. (a) Western blotting analysis for DSS crosslinked FLAG-gB 23-431. HEK 293FT cells transfected
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature11700 Figure 1: RIP3 as a potential Sirt2 interacting protein. Transfected Flag-tagged Sirt2 was immunoprecipitated from cells and eluted from the Sepharose beads using Flag peptide.
More informationMCB130 Midterm. GSI s Name:
1. Peroxisomes are small, membrane-enclosed organelles that function in the degradation of fatty acids and in the degradation of H 2 O 2. Peroxisomes are not part of the secretory pathway and peroxisomal
More informationTranslation. Host Cell Shutoff 1) Initiation of eukaryotic translation involves many initiation factors
Translation Questions? 1) How does poliovirus shutoff eukaryotic translation? 2) If eukaryotic messages are not translated how can poliovirus get its message translated? Host Cell Shutoff 1) Initiation
More informationNature Methods: doi: /nmeth Supplementary Figure 1
Supplementary Figure 1 Subtiligase-catalyzed ligations with ubiquitin thioesters and 10-mer biotinylated peptides. (a) General scheme for ligations between ubiquitin thioesters and 10-mer, biotinylated
More informationhemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics)
Proc. Natl. Acad. Sci. USA Vol. 73, No. 6, pp. 242-246, June 976 Microbiology Mapping of the influenza virus genome: Identification of the hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide
More informationProtein Modeling Event
Protein Modeling Event School Name: School Number: Team Member 1: Team Member 2: : Pre-Build Score: On-Site Build Score: Test Score: Tie Breaker: Total: Final Rank: Part I: Pre-Build (40% of total score)
More informationProblem Set 5 KEY
2006 7.012 Problem Set 5 KEY ** Due before 5 PM on THURSDAY, November 9, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You are studying the development
More informationCharacterization of Influenza Hemagglutinin Mutants for the Elucidation of Key Residues Effect on Activation
University of Tennessee, Knoxville Trace: Tennessee Research and Creative Exchange University of Tennessee Honors Thesis Projects University of Tennessee Honors Program 5-2013 Characterization of Influenza
More informationAttribution: University of Michigan Medical School, Department of Microbiology and Immunology
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution
More informationInfluenza A H1N1 HA ELISA Pair Set
Influenza A H1N1 HA ELISA Pair Set for H1N1 ( A/Puerto Rico/8/1934 ) HA Catalog Number : SEK11684 To achieve the best assay results, this manual must be read carefully before using this product and the
More informationAntiviral Drugs Lecture 5
Antiviral Drugs Lecture 5 Antimicrobial Chemotherapy (MLAB 366) 1 Dr. Mohamed A. El-Sakhawy 2 Introduction Viruses are microscopic organisms that can infect all living cells. They are parasitic and multiply
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationReceived 12 August 2006/Returned for modification 16 October 2006/Accepted 16 January 2007
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2007, p. 1596 1607 Vol. 51, No. 5 0066-4804/07/$08.00 0 doi:10.1128/aac.01009-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Addition
More informationEffects of Second Messengers
Effects of Second Messengers Inositol trisphosphate Diacylglycerol Opens Calcium Channels Binding to IP 3 -gated Channel Cooperative binding Activates Protein Kinase C is required Phosphorylation of many
More informationReceived 18 March 2010/Accepted 2 June 2010
JOURNAL OF VIROLOGY, Sept. 2010, p. 8422 8432 Vol. 84, No. 17 0022-538X/10/$12.00 doi:10.1128/jvi.00599-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Vaccinia Virus A25 and
More informationViral vaccines. Lec. 3 أ.د.فائزة عبد هللا مخلص
Lec. 3 أ.د.فائزة عبد هللا مخلص Viral vaccines 0bjectives 1-Define active immunity. 2-Describe the methods used for the preparation of attenuated live & killed virus vaccines. 3- Comparison of Characteristics
More informationSupplementary Information
Supplementary Information HBV maintains electrostatic homeostasis by modulating negative charges from phosphoserine and encapsidated nucleic acids Authors: Pei-Yi Su 1,2,3, Ching-Jen Yang 2, Tien-Hua Chu
More informationAntibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin
Virology 325 (2004) 425 431 www.elsevier.com/locate/yviro Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin
More informationProtein MultiColor Stable, Low Range
Product Name: DynaMarker Protein MultiColor Stable, Low Range Code No: DM670L Lot No: ******* Size: 200 μl x 3 (DM670 x 3) (120 mini-gel lanes) Storage: 4 C Stability: 12 months at 4 C Storage Buffer:
More informationMutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey
Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC
More informationAn aldose contains an aldehyde functionality A ketose contains a ketone functionality
RCT Chapter 7 Aldoses and Ketoses; Representative monosaccharides. (a)two trioses, an aldose and a ketose. The carbonyl group in each is shaded. An aldose contains an aldehyde functionality A ketose contains
More informationSupplemental Figure 1
Supplemental Figure 1 A S100A4: SFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMCNEFFEGFPDK Overlap: SF G DE KLM LD N D VDFQEY VFL I M N FF G PD S100A2: SFVGEKVDEEGLKKLMGSLDENSDQQVDFQEYAVFLALITVMCNDFFQGCPDR
More informationEMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)
AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,
More informationInfluenza or flu is a
Clinical and Research Area Infectious Diseases Influenza Virus Types A and B Influenza or flu is a respiratory illness that is caused by influenza viruses. Influenza viruses type A and type B cause seasonal
More informationAn Exploration to Determine if Fab Molecules are Efficacious in Neutralizing Influenza H1 and H3 Subtypes. Nick Poulton June September 2012
An Exploration to Determine if Fab Molecules are Efficacious in Neutralizing Influenza H1 and H3 Subtypes Nick Poulton June 2012- September 2012 Epidemiology of Influenza Infection Causes between 250,000
More informationChapter 6- An Introduction to Viruses*
Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses
More informationInfluenza B Hemagglutinin / HA ELISA Pair Set
Influenza B Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK11053 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized
More informationHIV 101: Fundamentals of HIV Infection
HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able
More informationVaccinia Virus H2 Protein Is an Essential Component of a Complex Involved in Virus Entry and Cell-Cell Fusion
JOURNAL OF VIROLOGY, Apr. 2005, p. 4744 4754 Vol. 79, No. 8 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.8.4744 4754.2005 Vaccinia Virus H2 Protein Is an Essential Component of a Complex Involved in Virus
More information